arrow
M

Massimo Marano

university campus bio-medico
H指数:21
被引数:1,530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The safety and tolerability of opicapone in elderly Parkinson’s disease patients: a real-world, multicenter, retrospective study

奥匹卡朋在老年帕金森病患者中的安全性和耐受性:一项真实世界、多中心、回顾性研究

2026-10-030
PRE
Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial

盐酸胞磷胆碱作为帕金森病辅助治疗的疗效:一项随机、双盲试验

2026-08-010
OAAI
Constrained Spherical Deconvolution White Matter Tractography in Neuro-Oncology and Deep Brain Stimulation: An Illustrative Case Series

神经肿瘤学和深部脑刺激中的约束性球形解卷积白质束成像:一个说明性病例系列

2026-05-020
OA
Diagnostic Potential of Combined Skin Morphometric Analysis and Salivary Alpha-Synuclein Oligomers in Parkinson’s Disease

联合皮肤形态计量分析与唾液阿尔法突触核蛋白寡聚物在帕金森病中的诊断潜力

Cells
IF5.2
2026-04-010
OAAI
Foslevodopa/Foscarbidopa Overnight Administration Improves Nocturia in Patients with Parkinson's Disease: Evidence from a Real-World Study

左旋多巴/卡比多巴福司曲星过夜给药改善帕金森病患者的夜尿症:来自真实世界研究的证据

2026-03-010
PRE
Study of POLR3A variants in a family trio suggests mutation-specific pathogenetic mechanisms: insights from integrative OMIC approaches

对POLR3A变异在家庭三联体中的研究提示了突变特异性的致病机制:整合组学方法的见解

2026-02-040
OAAI
Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease

血浆葡萄糖神经酰胺水平与GBA1相关帕金森病运动障碍负担之间的关联

2026-01-130
OAAI
Longitudinal Study of Salivary Biomarkers in the Definition of Clinico-Molecular Progression of Parkinson's Disease

唾液生物标志物在帕金森病临床-分子进展定义中的纵向研究

2025-09-270
OAAI